Back to Search Start Over

Hydrochlorothiazide use, sun exposure, and risk of keratinocyte cancer

Authors :
Jeffrey J. VanWormer
Eseoghene B. Abokede
Richard L. Berg
Source :
BMC Public Health, Vol 22, Iss 1, Pp 1-7 (2022)
Publication Year :
2022
Publisher :
BMC, 2022.

Abstract

Abstract Background Keratinocyte cancer (KC) rates are increasing in the U.S., particularly in older age groups. Use of hydrochlorothiazide (HCTZ), due to its photosensitizing properties, and high sun exposure are two known NMSC risk factors, but their synergistic effects are undetermined. The purpose of this study was to examine the development of NMSC between adults who did and did not use HCTZ, as well as those with high and low sun exposure. Methods A retrospective case–control sample was assembled from adult patients in north-central Wisconsin (USA). Duration of HCTZ use and occupational sun exposure were extracted from electronic health records, along with a linked survey of lifetime sun exposure. Results There were 333 cases and 666 controls in the analytical sample. A significant main effect was observed for HCTZ duration in the full sample. Under low sun exposure, the odds of NMSC was 14% greater for each additional year of HCTZ use (aOR = 1.14 [1.11, 1.18], p

Details

Language :
English
ISSN :
14712458
Volume :
22
Issue :
1
Database :
Directory of Open Access Journals
Journal :
BMC Public Health
Publication Type :
Academic Journal
Accession number :
edsdoj.f3c8abeda3e74861b9b4e7de1a7aa685
Document Type :
article
Full Text :
https://doi.org/10.1186/s12889-022-13705-9